The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
Warning Letter to Gotay’s Group Systems - Spanish
20201033: Alstom S.A.; Bombardier Inc.
20201639: Brightstar Capital Partners Fund II, L.P.; SoftBank Group Corporation
20210027: Surgalign Holdings, Inc.; Pawel Lewicki
20210028: Alphabet Inc.; Intuit Inc.
20210029: Partners Group Raven Parent, LLC; Arcanum Infrastructure, LLC
20210037: KKR Core Holding Company LLC; CNT Holdings I Corp.
20210038: Switchback Energy Acquisition Corporation; ChargePoint, Inc.
20210045: Landmark Services Cooperative; Countryside Cooperative
20210046: H.I.G. Advantage Buyout Fund, L.P.; The Resolute Fund III, L.P.
20210048: GHO Capital Fund II LP; Excellere Capital Fund II, LP
20210052: NextEra Energy, Inc.; Blackstone Power & Natural Resources Holdco L.P.
20210056: Snow Phipps III, L.P.; Innovative Labeling Solutions, Inc.
20210060: LS Group Parent OpCo Holdings Inc.; LS OpCo, LLC
Marc Ching, In the Matter of
In response to an FTC complaint, in April 2020, a California-based marketer of a supplement consisting mainly of Vitamin C and herbal extracts has agreed to a preliminary order barring him from claiming that it is effective at treating, preventing, or reducing the risk of COVID-19. Pending the resolution of a parallel administrative case, the proposed preliminary order also bars Marc Ching, doing business as Whole Leaf Organics, from claiming that three CBD-based products he sells are effective cancer treatments. The Commission approved the final administrative order in this case in October 2020.